BioSpace News Archive

Omeros Corporation confirmed that earlier this month the company submitted to the U.S. Food and Drug Administration its response to the Agency’s Complete Response Letter for narsoplimab in the treatment of hematopoietic stem cell transplant-associated thrombotic microangiopathy.

Homecare oxygen concentrators are usually used in providing supplemental oxygen to wide range of patients with respiratory problems.

Fact.MR – A Market Research and Competitive Intelligence Provider: According to Fact.MR, the global specialty medical chairs market is expected to reach $5 billion in 2020, growing at a CAGR of 5% between 2016 and 2020.

Fact.MR – A Market Research and Competitive Intelligence Provider: In a recent market analysis, the carbapenem-based antibiotics market would exceed US$ 1.8 billion in 2031.

Anesthesia refers to a form of medical treatment that induces temporary loss of sensation in patients for various medical purposes.

Massive advancements in the biology and the life sciences sector coupled with the growing applications in numerous end-users have led to a bio-revolution around the world.

SiteOne will be responsible for research and early preclinical development activities; Vertex will be responsible for development, and commercialization.

Alterome Therapeutics, Inc. announced the closing of a $64M Series A financing.

Jan. 19, 2022 13:00 UTC Oral and IV products based on xeruborbactam (formerly known as QPX7728), and QPX9003 are advancing in clinical studies All three products have received Qualified Infectious Disease Product Designation (QIDP) from the U.S. Food and Drug Administration (FDA) for multiple potential indications The Biomedical Advanced Research and Development Authority (BARDA) exercised a $15M option in 2021 to support continued clinical advancement of pipe

ChemoCentryx, Inc., (Nasdaq: CCXI), today announced that TAVNEOS ® (avacopan) has been approved within the European Union in combination with a rituximab or cyclophosphamide regimen for the treatment of adult patients with severe, active granulomatosis polyangiitis (GPA) or microscopic polyangiitis (MPA), the two main forms of ANCA-associated vasculitis.